Pediatric Hematology/Oncology

Melanoma/Skin Cancer

Questions discussed in this category

What systemic therapy would you offer a patient with metastatic melanoma who is BRAF WT and developed metastases while on adjuvant nivolumab?

2 Answers available

How do you approach melanoma patients with a positive sentinel node with extra-nodal extension for definitive surgical management?

Is completing nodal dissection warranted for surgical management?

1 Answer available

What surveillance plan would you recommend for stage IV melanoma patients who achieve a CR or stable PR response with immunotherapy?

1 Answer available

What surveillance imaging do you obtain for stage III melanoma patients after completing systemic adjuvant therapy?

1 Answer available

What scenario would prophylactic Tocilizumab be considered to prevent Ipilimumab+Nivolumab (immunotherapy) induced toxicity in malignant melanoma?

1 Answer available

When treating patients with immune checkpoint inhibitors, do you routinely check markers of endocrinopathies such as TSH/ACTH, or only when a patient has symptoms?

If so, how often do you check these labs?

1 Answer available

Papers discussed in this category

European journal of cancer (Oxford, England : 1990), 2017-04

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma.

N Engl J Med, 2017 Jun 8

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Related Topics in Pediatric Hematology/Oncology